Analytic Investors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Analytic Investors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-28,699	Closed	-$698K	–	671
2015 Q2	$698K	Hold	28,699	–	–	0.01%	421
2015 Q1	$668K	Buy	28,699 +7,094	+33%	+$188K	0.01%	412
2014 Q4	$543K	Sell	21,605 -2,080	-9%	-$61K	0.01%	417
2014 Q3	$737K	Sell	23,685 -1,668	-7%	-$45.2K	0.01%	412
2014 Q2	$656K	Sell	25,353 -10,492	-29%	-$233K	0.01%	380
2014 Q1	$838K	Buy	35,845 +21,134	+144%	+$462K	0.01%	377
2013 Q4	$373K	Sell	14,711 -3,604	-20%	-$81.4K	0.01%	417
2013 Q3	$374K	Buy	+18,315	New	+$408K	0.01%	424

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Analytic Investors's SGNT Position: Q3 2015 in Review

Analytic Investors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 28,699 shares — an estimated $698K sold.

Analytic Investors first reported a position in SGNT in Q3 2013 and held it in 8 quarters. The position peaked at $838K in Q1 2014. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

Analytic Investors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Analytic Investors sold 28,699 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $698K.
Analytic Investors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 8 quarters.
Analytic Investors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $838K in Q1 2014.
127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.